Abstract | AIM: To investigate molecular epidemiology of extended-spectrum β-lactamase/ESBL and plasmid-mediated AmpC β-lactamase/pAmpC producing Gram-negative bacteria causing urinary tract infections (UTIs) in Zenica-Doboj Canton, Bosnia and Herzegovina, in the period Decembar 2009-May 2010. METHODS:
Antibiotic susceptibility was determined by disc diffusion and broth microdilution according to CLSI guidelines. Double-disk synergy test was performed in order to screen for ESBLs/pAmpC beta-lactamases. PCR was used to detect bla(ESBL)/bla(ampC)/bla(carb) genes. Genetic relatedness of the strains was determined by pulsed-field-gel-electrophoresis (PFGE). RESULTS: Among 85 patients with UTIs caused by ESBL producing isolates, 44 (51.8%) were from in-patients and 41 (48.2%) from outpatients. Klebsiella spp. was the most frequently isolated from in-patients, in 28 (63.6%) cases. Among outpatients, Klebsiella spp./Escherichia coli were the most frequently isolated, in 19 (46.3%)/16 (39.0%) cases. Twenty-one (75.0%) from hospital and nine (47.4%) from outpatient Klebsiella spp. isolates were positive for blaTEM, whereas 27 (96.4%) from in-patients and 6 (31.6%) from outpatient were bla(CTX-M) positive (18 hospital and five outpatient isolates were encoding bla(CTX- M-15)). One Klebsiella oxytoca and one Enterobacter cloacae inpatient isolates were positive for blaCTX-M-28. One Klebsiella pneumoniae outpatient isolate were positive for bla(CTX-M-22) and one E. coli for bla(CTX-M-3). One hospital Proteus mirabilis strain was positive for bla(CMY-2) and two Klebsiella spp. strains for blaDHA-1, whereas two E. coli, one K. oxytoca and one Proteus vulgaris outpatient strains were positive for bla(CMY-2). CONCLUSION: Identification of bla(CTX-M-3), bla(CTX-M-22) and bla(CTX-M-28) among Enterobacteriaceae is uncommon. In this study we report the emergency of CMY-2 and DHA-1 plasmid-mediated beta-lactamases.
|
Authors | Amir Ibrahimagić, Branka Bedenić, Farah Kamberović, Selma Uzunović |
Journal | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
(J Infect Chemother)
Vol. 21
Issue 5
Pg. 363-9
(May 2015)
ISSN: 1437-7780 [Electronic] Netherlands |
PMID | 25638292
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Bacterial Proteins
- Escherichia coli Proteins
- beta-lactamase CMY-2
- beta-lactamase CTX-M-15
- beta-lactamase CTX-M-3
- AmpC beta-lactamases
- CTX-M-28 beta-lactamase, Klebsiella pneumoniae
- beta-Lactamases
- beta-lactamase CTX-M-22, E coli
- beta-lactamase DHA-1, Klebsiella pneumoniae
|
Topics |
- Ambulatory Care
- Bacterial Proteins
(genetics)
- Bosnia and Herzegovina
(epidemiology)
- Citrobacter freundii
(enzymology, genetics, isolation & purification)
- Disk Diffusion Antimicrobial Tests
- Electrophoresis, Gel, Pulsed-Field
- Enterobacter cloacae
(enzymology, genetics, isolation & purification)
- Enterobacteriaceae
(enzymology, genetics, isolation & purification)
- Escherichia coli
(enzymology, genetics, isolation & purification)
- Escherichia coli Proteins
(genetics)
- Hospitalization
- Humans
- Infant
- Klebsiella oxytoca
(enzymology, genetics, isolation & purification)
- Klebsiella pneumoniae
(enzymology, genetics, isolation & purification)
- Middle Aged
- Molecular Epidemiology
- Molecular Typing
- Plasmids
(genetics)
- Prevalence
- Proteus mirabilis
(enzymology, genetics, isolation & purification)
- Urinary Tract Infections
(epidemiology, genetics, microbiology)
- beta-Lactamases
(genetics)
|